Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage


Khakoo, S.I., Coles, C.J., Armstrong, J.S. and Barry, R.E. (1995) Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage. Journal of Clinical Gastroenterology, 20, (3), 244-247. (PMID:7797836).

Download

Full text not available from this repository.

Description/Abstract

3,4-Methylenedioxymetamphetamine ("ecstasy") has previously been reported to cause an acute hepatitis that may progress to liver failure. We present the first recorded case of ecstasy-induced accelerated hepatic fibrosis.

Item Type: Article
ISSNs: 0192-0790 (print)
1539-2031 (electronic)
Related URLs:
Keywords: 3,4-methylenedioxymetamphetamine, liver, fibrosis, drug reaction, toxicity
Subjects: R Medicine > RC Internal medicine
Divisions: Faculty of Medicine > Infection, Inflammation and Immunity
ePrint ID: 337659
Date Deposited: 22 Jun 2012 13:11
Last Modified: 27 Mar 2014 20:21
URI: http://eprints.soton.ac.uk/id/eprint/337659

Actions (login required)

View Item View Item